论文部分内容阅读
以吡虫啉和甲氨基阿维菌素苯甲酸盐为有效成分,以起始外观、冷藏外观[(0~5)℃,7 d]、热贮外观((54±2)℃,14 d)、和稀释稳定性(1∶200倍液)合格标准,通过对不同乳化剂、助溶剂、抗冻剂和水的配方筛选实验,得到3.5%吡虫啉.甲氨基阿维菌素苯甲酸盐微乳剂的最佳制剂配方.优化的配方为:甲氨基阿维菌素苯甲酸盐0.2%,吡虫啉3.3%,助溶剂30%~35%,乳化剂10%~15%,抗冻剂5%,水余量.实验表明,该复配微乳剂具有贮藏稳定性好、高效安全等特点.
With imidacloprid and emamectin benzoate as starting materials, the appearance of appearance, the appearance of refrigeration ([0 ~ 5] ℃, 7 d], the thermal storage appearance (54 ± 2 ℃, 14 d) , And dilution stability (1: 200 times) pass the standard, through the different emulsifying agent, cosolvent, cryoprotectant and water formula screening experiment, get 3.5% imidacloprid.Methyl avermectin benzoate micro The optimum formulation of the emulsion is as follows: 0.2% of emamectin benzoate, 3.3% of imidacloprid, 30% ~ 35% of cosolvent, 10% ~ 15% of emulsifier, , Water balance.The experiments show that the compound microemulsion has the characteristics of good storage stability, high efficiency and safety.